Pharmacy
HIMSS22
<p>Bob Katter, president of First Databank, explains how the FDB Vela electronic prescribing network can improve contracting and access for clinicians and pharmacies.</p>
The BA.4 and BA.5 lineages of the omicron variant are currently causing most cases of COVID-19 and are predicted to circulate this fall.
BCBS is accusing Teva of offering coupons to prevent consumers from switching to a generic, lower-cost version of Copaxone.
Health officials are trying to move all vaccines to intradermal dosing as in a strategy to stretch supply.
Part D's programmatic structure may lead to plan sponsors preferring higher-cost versions of hepatitis C drugs, OIG finds.
The treatment has been cleared for anyone 12 years old and older who is at high risk for severe COVID-19, including hospitalization and death.
The Supreme Court is fast-tracking the cases as the Omicron variant is causing COVID-19 cases to surge nationwide.
When unvaccinated adults are asked what would convince them to get a COVID-19 vaccine, half say nothing.
OIG found gaps between the number of providers authorized to treat patients with medication and the number of those who need care.
The rule requires all healthcare workers in facilities that participate in the Medicare and Medicaid program to get vaccinated.